pre-seed
Stage
1
Investors
About
HepaTx develops off-the-shelf regenerative medicine therapies based on stem cells to treat late-stage liver disease as an alternative to liver transplantation.
Explore HepaTx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.